168 related articles for article (PubMed ID: 24236632)
1. Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level.
Pezzuto A; Spoto C; Vincenzi B; Tonini G
J Comp Eff Res; 2013 May; 2(3):335-43. PubMed ID: 24236632
[TBL] [Abstract][Full Text] [Related]
2. Smokers with airway obstruction are more likely to quit smoking.
Bednarek M; Gorecka D; Wielgomas J; Czajkowska-Malinowska M; Regula J; Mieszko-Filipczyk G; Jasionowicz M; Bijata-Bronisz R; Lempicka-Jastrzebska M; Czajkowski M; Przybylski G; Zielinski J
Thorax; 2006 Oct; 61(10):869-73. PubMed ID: 16809415
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
[TBL] [Abstract][Full Text] [Related]
5. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
[TBL] [Abstract][Full Text] [Related]
6. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
Lam S; Patel PN
Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
[TBL] [Abstract][Full Text] [Related]
7. Managing tobacco use: the neglected cardiovascular disease risk factor.
Rigotti NA; Clair C
Eur Heart J; 2013 Nov; 34(42):3259-67. PubMed ID: 24014389
[TBL] [Abstract][Full Text] [Related]
8. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.
Scanlon PD; Connett JE; Waller LA; Altose MD; Bailey WC; Buist AS; Tashkin DP;
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):381-90. PubMed ID: 10673175
[TBL] [Abstract][Full Text] [Related]
9. Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran.
Heydari G; Talischi F; Tafti SF; Masjedi MR
Int J Tuberc Lung Dis; 2012 Feb; 16(2):268-72. PubMed ID: 22236931
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
[TBL] [Abstract][Full Text] [Related]
11. Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study.
Pezzuto A; Stellato M; Catania G; Mazzara C; Tonini S; Caricato M; Crucitti P; Tonini G
J Breath Res; 2018 Aug; 12(4):046007. PubMed ID: 29967309
[TBL] [Abstract][Full Text] [Related]
12. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of varenicline for smoking cessation: a 1-year follow-up study.
Grassi MC; Enea D; Ferketich AK; Lu B; Pasquariello S; Nencini P
J Subst Abuse Treat; 2011 Jul; 41(1):64-70. PubMed ID: 21349681
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study.
Andreas S; Chenot JF; Diebold R; Peachey S; Mann K
Eur Addict Res; 2013; 19(1):47-54. PubMed ID: 22987095
[TBL] [Abstract][Full Text] [Related]
15. Varenicline in the management of smoking cessation: a single technology appraisal.
Hind D; Tappenden P; Peters J; Kenjegalieva K
Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: Functional analysis.
Pezzuto A; Carico E
Clin Respir J; 2020 Jan; 14(1):29-34. PubMed ID: 31613417
[TBL] [Abstract][Full Text] [Related]
18. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
[TBL] [Abstract][Full Text] [Related]
19. Nasal and systemic inflammatory profile after short term smoking cessation.
Rodrigues FM; Ramos D; Xavier RF; Ito JT; Souza AP; Fernandes RA; Cecchini R; Rossi e Silva RC; Macchione M; Toledo-Arruda AC; Guarnier FA; Ramos EM
Respir Med; 2014 Jul; 108(7):999-1006. PubMed ID: 24863424
[TBL] [Abstract][Full Text] [Related]
20. Smoking cessation effectiveness in smokers with COPD and asthma under real life conditions.
Gratziou Ch; Florou A; Ischaki E; Eleftheriou K; Sachlas A; Bersimis S; Zakynthinos S
Respir Med; 2014 Apr; 108(4):577-83. PubMed ID: 24560410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
